CD79A and small cell lung carcinoma: Our study found that the metabolic pathways of different substances of MCI were mainly enriched in five pathways including pathways in cancer and intestinal immune network for IgA production and alpa-Linolenic acid metabolism and small-cell lung cancer and Th17 cell differentiation.